Ishigami, T.; Nanki, T.; Sugawara, T.; Uchida, K.; Takeda, H.; Sawasaki, T.; Chen, L.; Doi, H.; Arakawa, K.; Saigo, S.;
et al. Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical Atherosclerosis. Methods Protoc. 2021, 4, 83.
https://doi.org/10.3390/mps4040083
AMA Style
Ishigami T, Nanki T, Sugawara T, Uchida K, Takeda H, Sawasaki T, Chen L, Doi H, Arakawa K, Saigo S,
et al. Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical Atherosclerosis. Methods and Protocols. 2021; 4(4):83.
https://doi.org/10.3390/mps4040083
Chicago/Turabian Style
Ishigami, Tomoaki, Toshihiro Nanki, Takuya Sugawara, Kotaro Uchida, Hiroyuki Takeda, Tatsuya Sawasaki, Lin Chen, Hiroshi Doi, Kentaro Arakawa, Sae Saigo,
and et al. 2021. "Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical Atherosclerosis" Methods and Protocols 4, no. 4: 83.
https://doi.org/10.3390/mps4040083
APA Style
Ishigami, T., Nanki, T., Sugawara, T., Uchida, K., Takeda, H., Sawasaki, T., Chen, L., Doi, H., Arakawa, K., Saigo, S., Yoshimi, R., Taguri, M., Kimura, K., Hibi, K., Wakui, H., Azushima, K., Tamura, K., & on behalf of ORACLE Arthritis Investigators.
(2021). Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical Atherosclerosis. Methods and Protocols, 4(4), 83.
https://doi.org/10.3390/mps4040083
